Physician profile
Matthew R Eager
NPI 1699830133
$16,324.32
in general payments reported to CMS, 2019-2025
18 companies · $2,554 in 2025
The $2,554 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,245 · 2020: $289 · 2021: $569 · 2022: $7,559 · 2023: $1,518 · 2024: $591 · 2025: $2,554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,909 · Food and Beverage: $1,754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,908.56 |
| Food and Beverage | $1,753.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $14,148.80 | 2019-2025 | Excelsius Gps, Caliber, Excelsiusgps Robotic Navigation System |
| Centinel Spine, LLC | $1,062.83 | 2019 | |
| Boston Scientific Corporation | $205.68 | 2022-2023 | |
| Abbott Laboratories | $195.11 | 2021 | |
| Alexion Pharmaceuticals, INC. | $119.83 | 2022 | |
| Si-Bone, INC. | $117.59 | 2019-2025 | |
| Amgen INC. | $80.38 | 2020-2025 | Evenity |
| Stryker Corporation | $77.34 | 2021 | |
| Zimmer Biomet Holdings, INC. | $74.48 | 2019 | |
| Depuy Synthes Sales INC. | $46.48 | 2019-2023 | Monovisc, Orthovisc |
| Pacira Pharmaceuticals Incorporated | $44.48 | 2021-2023 | Iovera |
| Bioventus LLC | $35.61 | 2024-2025 | Durolane |
| Medtronic, INC. | $30.21 | 2021 | |
| Baxter Healthcare | $23.71 | 2024 | Floseal |
| Djo, LLC | $17.65 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $15.82 | 2025 | Euflexxa |
| Glaxosmithkline, LLC. | $14.85 | 2020 | |
| Merck Sharp & Dohme LLC | $13.47 | 2024 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Eager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.